The global Branded Generics market is projected to grow from US$ 326 million in 2024 to US$ 523.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast period.

Branded Generics Market

This report mainly focuses on branded generics market. Branded generics are generic drugs that have been given a proprietary market name. They may be marketed similarly to how branded drugs are. Branded generic drugs attach proprietary names to generic drug molecules.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Branded Generics, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Branded Generics, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Branded Generics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Branded Generics sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Branded Generics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Branded Generics sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Branded Generics Market Report

Report Metric	Details
Report Name	Branded Generics Market
Accounted market size in 2024	US$ 326 million
Forecasted market size in 2030	US$ 523.1 million
CAGR	8.2
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Oral Parenteral Topical Other
Segment by Application	Oncology Cardiovascular Diseases Diabetes Neurology Gastrointestinal Diseases Others
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Eva Pharmaceutical Industries, Pfizer, Sun Pharmaceutical Industries, Aspen Pharmacare Holding, Abbott Laboratories, Bausch Health
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Branded Generics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Branded Generics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Branded Generics sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Branded Generics Market growing?

Ans: The Branded Generics Market witnessing a CAGR of 8.2 during the forecast period 2024-2030.

What is the Branded Generics Market size in 2030?

Ans: The Branded Generics Market size in 2030 will be US$ 523.1 million.

Who are the main players in the Branded Generics Market report?

Ans: The main players in the Branded Generics Market are Eva Pharmaceutical Industries, Pfizer, Sun Pharmaceutical Industries, Aspen Pharmacare Holding, Abbott Laboratories, Bausch Health

What are the Application segmentation covered in the Branded Generics Market report?

Ans: The Applications covered in the Branded Generics Market report are Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Others

What are the Type segmentation covered in the Branded Generics Market report?

Ans: The Types covered in the Branded Generics Market report are Oral, Parenteral, Topical, Other

1 Study Coverage

1.1 Branded Generics Product Introduction

1.2 Market by Type

1.2.1 Global Branded Generics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Oral

1.2.3 Parenteral

1.2.4 Topical

1.2.5 Other

1.3 Market by Application

1.3.1 Global Branded Generics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Oncology

1.3.3 Cardiovascular Diseases

1.3.4 Diabetes

1.3.5 Neurology

1.3.6 Gastrointestinal Diseases

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Branded Generics Sales Estimates and Forecasts 2019-2030

2.2 Global Branded Generics Revenue by Region

2.2.1 Global Branded Generics Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Branded Generics Revenue by Region (2019-2024)

2.2.3 Global Branded Generics Revenue by Region (2025-2030)

2.2.4 Global Branded Generics Revenue Market Share by Region (2019-2030)

2.3 Global Branded Generics Sales Estimates and Forecasts 2019-2030

2.4 Global Branded Generics Sales by Region

2.4.1 Global Branded Generics Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Branded Generics Sales by Region (2019-2024)

2.4.3 Global Branded Generics Sales by Region (2025-2030)

2.4.4 Global Branded Generics Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Branded Generics Sales by Manufacturers

3.1.1 Global Branded Generics Sales by Manufacturers (2019-2024)

3.1.2 Global Branded Generics Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Branded Generics in 2023

3.2 Global Branded Generics Revenue by Manufacturers

3.2.1 Global Branded Generics Revenue by Manufacturers (2019-2024)

3.2.2 Global Branded Generics Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Branded Generics Revenue in 2023

3.3 Global Key Players of Branded Generics, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Branded Generics Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Branded Generics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Branded Generics, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Branded Generics, Product Offered and Application

3.8 Global Key Manufacturers of Branded Generics, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Branded Generics Sales by Type

4.1.1 Global Branded Generics Historical Sales by Type (2019-2024)

4.1.2 Global Branded Generics Forecasted Sales by Type (2025-2030)

4.1.3 Global Branded Generics Sales Market Share by Type (2019-2030)

4.2 Global Branded Generics Revenue by Type

4.2.1 Global Branded Generics Historical Revenue by Type (2019-2024)

4.2.2 Global Branded Generics Forecasted Revenue by Type (2025-2030)

4.2.3 Global Branded Generics Revenue Market Share by Type (2019-2030)

4.3 Global Branded Generics Price by Type

4.3.1 Global Branded Generics Price by Type (2019-2024)

4.3.2 Global Branded Generics Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Branded Generics Sales by Application

5.1.1 Global Branded Generics Historical Sales by Application (2019-2024)

5.1.2 Global Branded Generics Forecasted Sales by Application (2025-2030)

5.1.3 Global Branded Generics Sales Market Share by Application (2019-2030)

5.2 Global Branded Generics Revenue by Application

5.2.1 Global Branded Generics Historical Revenue by Application (2019-2024)

5.2.2 Global Branded Generics Forecasted Revenue by Application (2025-2030)

5.2.3 Global Branded Generics Revenue Market Share by Application (2019-2030)

5.3 Global Branded Generics Price by Application

5.3.1 Global Branded Generics Price by Application (2019-2024)

5.3.2 Global Branded Generics Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Branded Generics Market Size by Type

6.1.1 US & Canada Branded Generics Sales by Type (2019-2030)

6.1.2 US & Canada Branded Generics Revenue by Type (2019-2030)

6.2 US & Canada Branded Generics Market Size by Application

6.2.1 US & Canada Branded Generics Sales by Application (2019-2030)

6.2.2 US & Canada Branded Generics Revenue by Application (2019-2030)

6.3 US & Canada Branded Generics Market Size by Country

6.3.1 US & Canada Branded Generics Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Branded Generics Sales by Country (2019-2030)

6.3.3 US & Canada Branded Generics Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Branded Generics Market Size by Type

7.1.1 Europe Branded Generics Sales by Type (2019-2030)

7.1.2 Europe Branded Generics Revenue by Type (2019-2030)

7.2 Europe Branded Generics Market Size by Application

7.2.1 Europe Branded Generics Sales by Application (2019-2030)

7.2.2 Europe Branded Generics Revenue by Application (2019-2030)

7.3 Europe Branded Generics Market Size by Country

7.3.1 Europe Branded Generics Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Branded Generics Sales by Country (2019-2030)

7.3.3 Europe Branded Generics Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Branded Generics Market Size

8.1.1 China Branded Generics Sales (2019-2030)

8.1.2 China Branded Generics Revenue (2019-2030)

8.2 China Branded Generics Market Size by Application

8.2.1 China Branded Generics Sales by Application (2019-2030)

8.2.2 China Branded Generics Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Branded Generics Market Size by Type

9.1.1 Asia Branded Generics Sales by Type (2019-2030)

9.1.2 Asia Branded Generics Revenue by Type (2019-2030)

9.2 Asia Branded Generics Market Size by Application

9.2.1 Asia Branded Generics Sales by Application (2019-2030)

9.2.2 Asia Branded Generics Revenue by Application (2019-2030)

9.3 Asia Branded Generics Sales by Region

9.3.1 Asia Branded Generics Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Branded Generics Revenue by Region (2019-2030)

9.3.3 Asia Branded Generics Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Branded Generics Market Size by Type

10.1.1 Middle East, Africa and Latin America Branded Generics Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Branded Generics Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Branded Generics Market Size by Application

10.2.1 Middle East, Africa and Latin America Branded Generics Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Branded Generics Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Branded Generics Sales by Country

10.3.1 Middle East, Africa and Latin America Branded Generics Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Branded Generics Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Branded Generics Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Mylan NV

11.1.1 Mylan NV Company Information

11.1.2 Mylan NV Overview

11.1.3 Mylan NV Branded Generics Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Mylan NV Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Mylan NV Recent Developments

11.2 Novartis AG

11.2.1 Novartis AG Company Information

11.2.2 Novartis AG Overview

11.2.3 Novartis AG Branded Generics Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Novartis AG Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Novartis AG Recent Developments

11.3 Eva Pharmaceutical Industries

11.3.1 Eva Pharmaceutical Industries Company Information

11.3.2 Eva Pharmaceutical Industries Overview

11.3.3 Eva Pharmaceutical Industries Branded Generics Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Eva Pharmaceutical Industries Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Eva Pharmaceutical Industries Recent Developments

11.4 Pfizer

11.4.1 Pfizer Company Information

11.4.2 Pfizer Overview

11.4.3 Pfizer Branded Generics Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Pfizer Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Pfizer Recent Developments

11.5 Sun Pharmaceutical Industries

11.5.1 Sun Pharmaceutical Industries Company Information

11.5.2 Sun Pharmaceutical Industries Overview

11.5.3 Sun Pharmaceutical Industries Branded Generics Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Sun Pharmaceutical Industries Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Sun Pharmaceutical Industries Recent Developments

11.6 Aspen Pharmacare Holding

11.6.1 Aspen Pharmacare Holding Company Information

11.6.2 Aspen Pharmacare Holding Overview

11.6.3 Aspen Pharmacare Holding Branded Generics Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Aspen Pharmacare Holding Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Aspen Pharmacare Holding Recent Developments

11.7 Abbott Laboratories

11.7.1 Abbott Laboratories Company Information

11.7.2 Abbott Laboratories Overview

11.7.3 Abbott Laboratories Branded Generics Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Abbott Laboratories Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Abbott Laboratories Recent Developments

11.8 Bausch Health

11.8.1 Bausch Health Company Information

11.8.2 Bausch Health Overview

11.8.3 Bausch Health Branded Generics Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Bausch Health Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Bausch Health Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Branded Generics Industry Chain Analysis

12.2 Branded Generics Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Branded Generics Production Mode & Process

12.4 Branded Generics Sales and Marketing

12.4.1 Branded Generics Sales Channels

12.4.2 Branded Generics Distributors

12.5 Branded Generics Customers

13 Market Dynamics

13.1 Branded Generics Industry Trends

13.2 Branded Generics Market Drivers

13.3 Branded Generics Market Challenges

13.4 Branded Generics Market Restraints

14 Key Findings in The Global Branded Generics Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Mylan NV

Novartis

Eva Pharmaceutical Industries

Pfizer Inc

Sun Pharmaceutical Industries

Aspen Pharmacare Holding

Abbott Laboratories

Bausch Health

List of Tables

Table 1. Global Branded Generics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Oral

Table 3. Major Manufacturers of Parenteral

Table 4. Major Manufacturers of Topical

Table 5. Major Manufacturers of Other

Table 6. Global Branded Generics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Branded Generics Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Branded Generics Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Branded Generics Revenue by Region (2025-2030) & (US$ Million)

Table 10. Global Branded Generics Revenue Market Share by Region (2019-2024)

Table 11. Global Branded Generics Revenue Market Share by Region (2025-2030)

Table 12. Global Branded Generics Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 13. Global Branded Generics Sales by Region (2019-2024) & (K MT)

Table 14. Global Branded Generics Sales by Region (2025-2030) & (K MT)

Table 15. Global Branded Generics Sales Market Share by Region (2019-2024)

Table 16. Global Branded Generics Sales Market Share by Region (2025-2030)

Table 17. Global Branded Generics Sales by Manufacturers (2019-2024) & (K MT)

Table 18. Global Branded Generics Sales Share by Manufacturers (2019-2024)

Table 19. Global Branded Generics Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 20. Global Branded Generics Revenue Share by Manufacturers (2019-2024)

Table 21. Global Key Players of Branded Generics, Industry Ranking, 2022 VS 2023 VS 2024

Table 22. Branded Generics Price by Manufacturers 2019-2024 (USD/MT)

Table 23. Global Branded Generics Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 24. Global Branded Generics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Branded Generics as of 2023)

Table 25. Global Key Manufacturers of Branded Generics, Manufacturing Base Distribution and Headquarters

Table 26. Global Key Manufacturers of Branded Generics, Product Offered and Application

Table 27. Global Key Manufacturers of Branded Generics, Date of Enter into This Industry

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Branded Generics Sales by Type (2019-2024) & (K MT)

Table 30. Global Branded Generics Sales by Type (2025-2030) & (K MT)

Table 31. Global Branded Generics Sales Share by Type (2019-2024)

Table 32. Global Branded Generics Sales Share by Type (2025-2030)

Table 33. Global Branded Generics Revenue by Type (2019-2024) & (US$ Million)

Table 34. Global Branded Generics Revenue by Type (2025-2030) & (US$ Million)

Table 35. Global Branded Generics Revenue Share by Type (2019-2024)

Table 36. Global Branded Generics Revenue Share by Type (2025-2030)

Table 37. Branded Generics Price by Type (2019-2024) & (USD/MT)

Table 38. Global Branded Generics Price Forecast by Type (2025-2030) & (USD/MT)

Table 39. Global Branded Generics Sales by Application (2019-2024) & (K MT)

Table 40. Global Branded Generics Sales by Application (2025-2030) & (K MT)

Table 41. Global Branded Generics Sales Share by Application (2019-2024)

Table 42. Global Branded Generics Sales Share by Application (2025-2030)

Table 43. Global Branded Generics Revenue by Application (2019-2024) & (US$ Million)

Table 44. Global Branded Generics Revenue by Application (2025-2030) & (US$ Million)

Table 45. Global Branded Generics Revenue Share by Application (2019-2024)

Table 46. Global Branded Generics Revenue Share by Application (2025-2030)

Table 47. Branded Generics Price by Application (2019-2024) & (USD/MT)

Table 48. Global Branded Generics Price Forecast by Application (2025-2030) & (USD/MT)

Table 49. US & Canada Branded Generics Sales by Type (2019-2024) & (K MT)

Table 50. US & Canada Branded Generics Sales by Type (2025-2030) & (K MT)

Table 51. US & Canada Branded Generics Revenue by Type (2019-2024) & (US$ Million)

Table 52. US & Canada Branded Generics Revenue by Type (2025-2030) & (US$ Million)

Table 53. US & Canada Branded Generics Sales by Application (2019-2024) & (K MT)

Table 54. US & Canada Branded Generics Sales by Application (2025-2030) & (K MT)

Table 55. US & Canada Branded Generics Revenue by Application (2019-2024) & (US$ Million)

Table 56. US & Canada Branded Generics Revenue by Application (2025-2030) & (US$ Million)

Table 57. US & Canada Branded Generics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 58. US & Canada Branded Generics Revenue by Country (2019-2024) & (US$ Million)

Table 59. US & Canada Branded Generics Revenue by Country (2025-2030) & (US$ Million)

Table 60. US & Canada Branded Generics Sales by Country (2019-2024) & (K MT)

Table 61. US & Canada Branded Generics Sales by Country (2025-2030) & (K MT)

Table 62. Europe Branded Generics Sales by Type (2019-2024) & (K MT)

Table 63. Europe Branded Generics Sales by Type (2025-2030) & (K MT)

Table 64. Europe Branded Generics Revenue by Type (2019-2024) & (US$ Million)

Table 65. Europe Branded Generics Revenue by Type (2025-2030) & (US$ Million)

Table 66. Europe Branded Generics Sales by Application (2019-2024) & (K MT)

Table 67. Europe Branded Generics Sales by Application (2025-2030) & (K MT)

Table 68. Europe Branded Generics Revenue by Application (2019-2024) & (US$ Million)

Table 69. Europe Branded Generics Revenue by Application (2025-2030) & (US$ Million)

Table 70. Europe Branded Generics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 71. Europe Branded Generics Revenue by Country (2019-2024) & (US$ Million)

Table 72. Europe Branded Generics Revenue by Country (2025-2030) & (US$ Million)

Table 73. Europe Branded Generics Sales by Country (2019-2024) & (K MT)

Table 74. Europe Branded Generics Sales by Country (2025-2030) & (K MT)

Table 75. China Branded Generics Sales by Type (2019-2024) & (K MT)

Table 76. China Branded Generics Sales by Type (2025-2030) & (K MT)

Table 77. China Branded Generics Revenue by Type (2019-2024) & (US$ Million)

Table 78. China Branded Generics Revenue by Type (2025-2030) & (US$ Million)

Table 79. China Branded Generics Sales by Application (2019-2024) & (K MT)

Table 80. China Branded Generics Sales by Application (2025-2030) & (K MT)

Table 81. China Branded Generics Revenue by Application (2019-2024) & (US$ Million)

Table 82. China Branded Generics Revenue by Application (2025-2030) & (US$ Million)

Table 83. Asia Branded Generics Sales by Type (2019-2024) & (K MT)

Table 84. Asia Branded Generics Sales by Type (2025-2030) & (K MT)

Table 85. Asia Branded Generics Revenue by Type (2019-2024) & (US$ Million)

Table 86. Asia Branded Generics Revenue by Type (2025-2030) & (US$ Million)

Table 87. Asia Branded Generics Sales by Application (2019-2024) & (K MT)

Table 88. Asia Branded Generics Sales by Application (2025-2030) & (K MT)

Table 89. Asia Branded Generics Revenue by Application (2019-2024) & (US$ Million)

Table 90. Asia Branded Generics Revenue by Application (2025-2030) & (US$ Million)

Table 91. Asia Branded Generics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 92. Asia Branded Generics Revenue by Region (2019-2024) & (US$ Million)

Table 93. Asia Branded Generics Revenue by Region (2025-2030) & (US$ Million)

Table 94. Asia Branded Generics Sales by Region (2019-2024) & (K MT)

Table 95. Asia Branded Generics Sales by Region (2025-2030) & (K MT)

Table 96. Middle East, Africa and Latin America Branded Generics Sales by Type (2019-2024) & (K MT)

Table 97. Middle East, Africa and Latin America Branded Generics Sales by Type (2025-2030) & (K MT)

Table 98. Middle East, Africa and Latin America Branded Generics Revenue by Type (2019-2024) & (US$ Million)

Table 99. Middle East, Africa and Latin America Branded Generics Revenue by Type (2025-2030) & (US$ Million)

Table 100. Middle East, Africa and Latin America Branded Generics Sales by Application (2019-2024) & (K MT)

Table 101. Middle East, Africa and Latin America Branded Generics Sales by Application (2025-2030) & (K MT)

Table 102. Middle East, Africa and Latin America Branded Generics Revenue by Application (2019-2024) & (US$ Million)

Table 103. Middle East, Africa and Latin America Branded Generics Revenue by Application (2025-2030) & (US$ Million)

Table 104. Middle East, Africa and Latin America Branded Generics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 105. Middle East, Africa and Latin America Branded Generics Revenue by Country (2019-2024) & (US$ Million)

Table 106. Middle East, Africa and Latin America Branded Generics Revenue by Country (2025-2030) & (US$ Million)

Table 107. Middle East, Africa and Latin America Branded Generics Sales by Country (2019-2024) & (K MT)

Table 108. Middle East, Africa and Latin America Branded Generics Sales by Country (2025-2030) & (K MT)

Table 109. Mylan NV Company Information

Table 110. Mylan NV Description and Major Businesses

Table 111. Mylan NV Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 112. Mylan NV Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications

Table 113. Mylan NV Recent Developments

Table 114. Novartis AG Company Information

Table 115. Novartis AG Description and Major Businesses

Table 116. Novartis AG Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 117. Novartis AG Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications

Table 118. Novartis AG Recent Developments

Table 119. Eva Pharmaceutical Industries Company Information

Table 120. Eva Pharmaceutical Industries Description and Major Businesses

Table 121. Eva Pharmaceutical Industries Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 122. Eva Pharmaceutical Industries Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications

Table 123. Eva Pharmaceutical Industries Recent Developments

Table 124. Pfizer Company Information

Table 125. Pfizer Description and Major Businesses

Table 126. Pfizer Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 127. Pfizer Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications

Table 128. Pfizer Recent Developments

Table 129. Sun Pharmaceutical Industries Company Information

Table 130. Sun Pharmaceutical Industries Description and Major Businesses

Table 131. Sun Pharmaceutical Industries Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 132. Sun Pharmaceutical Industries Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications

Table 133. Sun Pharmaceutical Industries Recent Developments

Table 134. Aspen Pharmacare Holding Company Information

Table 135. Aspen Pharmacare Holding Description and Major Businesses

Table 136. Aspen Pharmacare Holding Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 137. Aspen Pharmacare Holding Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications

Table 138. Aspen Pharmacare Holding Recent Developments

Table 139. Abbott Laboratories Company Information

Table 140. Abbott Laboratories Description and Major Businesses

Table 141. Abbott Laboratories Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 142. Abbott Laboratories Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications

Table 143. Abbott Laboratories Recent Developments

Table 144. Bausch Health Company Information

Table 145. Bausch Health Description and Major Businesses

Table 146. Bausch Health Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 147. Bausch Health Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications

Table 148. Bausch Health Recent Developments

Table 149. Key Raw Materials Lists

Table 150. Raw Materials Key Suppliers Lists

Table 151. Branded Generics Distributors List

Table 152. Branded Generics Customers List

Table 153. Branded Generics Market Trends

Table 154. Branded Generics Market Drivers

Table 155. Branded Generics Market Challenges

Table 156. Branded Generics Market Restraints

Table 157. Research Programs/Design for This Report

Table 158. Key Data Information from Secondary Sources

Table 159. Key Data Information from Primary Sources

List of Figures

Figure 1. Branded Generics Product Picture

Figure 2. Global Branded Generics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Branded Generics Market Share by Type in 2023 & 2030

Figure 4. Oral Product Picture

Figure 5. Parenteral Product Picture

Figure 6. Topical Product Picture

Figure 7. Other Product Picture

Figure 8. Global Branded Generics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Branded Generics Market Share by Application in 2023 & 2030

Figure 10. Oncology

Figure 11. Cardiovascular Diseases

Figure 12. Diabetes

Figure 13. Neurology

Figure 14. Gastrointestinal Diseases

Figure 15. Others

Figure 16. Branded Generics Report Years Considered

Figure 17. Global Branded Generics Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Branded Generics Revenue 2019-2030 (US$ Million)

Figure 19. Global Branded Generics Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 20. Global Branded Generics Revenue Market Share by Region (2019-2030)

Figure 21. Global Branded Generics Sales 2019-2030 ((K MT)

Figure 22. Global Branded Generics Sales Market Share by Region (2019-2030)

Figure 23. US & Canada Branded Generics Sales YoY (2019-2030) & (K MT)

Figure 24. US & Canada Branded Generics Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Europe Branded Generics Sales YoY (2019-2030) & (K MT)

Figure 26. Europe Branded Generics Revenue YoY (2019-2030) & (US$ Million)

Figure 27. China Branded Generics Sales YoY (2019-2030) & (K MT)

Figure 28. China Branded Generics Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Asia (excluding China) Branded Generics Sales YoY (2019-2030) & (K MT)

Figure 30. Asia (excluding China) Branded Generics Revenue YoY (2019-2030) & (US$ Million)

Figure 31. Middle East, Africa and Latin America Branded Generics Sales YoY (2019-2030) & (K MT)

Figure 32. Middle East, Africa and Latin America Branded Generics Revenue YoY (2019-2030) & (US$ Million)

Figure 33. The Branded Generics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 34. The Top 5 and 10 Largest Manufacturers of Branded Generics in the World: Market Share by Branded Generics Revenue in 2023

Figure 35. Global Branded Generics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 36. Global Branded Generics Sales Market Share by Type (2019-2030)

Figure 37. Global Branded Generics Revenue Market Share by Type (2019-2030)

Figure 38. Global Branded Generics Sales Market Share by Application (2019-2030)

Figure 39. Global Branded Generics Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada Branded Generics Sales Market Share by Type (2019-2030)

Figure 41. US & Canada Branded Generics Revenue Market Share by Type (2019-2030)

Figure 42. US & Canada Branded Generics Sales Market Share by Application (2019-2030)

Figure 43. US & Canada Branded Generics Revenue Market Share by Application (2019-2030)

Figure 44. US & Canada Branded Generics Revenue Share by Country (2019-2030)

Figure 45. US & Canada Branded Generics Sales Share by Country (2019-2030)

Figure 46. U.S. Branded Generics Revenue (2019-2030) & (US$ Million)

Figure 47. Canada Branded Generics Revenue (2019-2030) & (US$ Million)

Figure 48. Europe Branded Generics Sales Market Share by Type (2019-2030)

Figure 49. Europe Branded Generics Revenue Market Share by Type (2019-2030)

Figure 50. Europe Branded Generics Sales Market Share by Application (2019-2030)

Figure 51. Europe Branded Generics Revenue Market Share by Application (2019-2030)

Figure 52. Europe Branded Generics Revenue Share by Country (2019-2030)

Figure 53. Europe Branded Generics Sales Share by Country (2019-2030)

Figure 54. Germany Branded Generics Revenue (2019-2030) & (US$ Million)

Figure 55. France Branded Generics Revenue (2019-2030) & (US$ Million)

Figure 56. U.K. Branded Generics Revenue (2019-2030) & (US$ Million)

Figure 57. Italy Branded Generics Revenue (2019-2030) & (US$ Million)

Figure 58. Russia Branded Generics Revenue (2019-2030) & (US$ Million)

Figure 59. China Branded Generics Sales Market Share by Type (2019-2030)

Figure 60. China Branded Generics Revenue Market Share by Type (2019-2030)

Figure 61. China Branded Generics Sales Market Share by Application (2019-2030)

Figure 62. China Branded Generics Revenue Market Share by Application (2019-2030)

Figure 63. Asia Branded Generics Sales Market Share by Type (2019-2030)

Figure 64. Asia Branded Generics Revenue Market Share by Type (2019-2030)

Figure 65. Asia Branded Generics Sales Market Share by Application (2019-2030)

Figure 66. Asia Branded Generics Revenue Market Share by Application (2019-2030)

Figure 67. Asia Branded Generics Revenue Share by Region (2019-2030)

Figure 68. Asia Branded Generics Sales Share by Region (2019-2030)

Figure 69. Japan Branded Generics Revenue (2019-2030) & (US$ Million)

Figure 70. South Korea Branded Generics Revenue (2019-2030) & (US$ Million)

Figure 71. China Taiwan Branded Generics Revenue (2019-2030) & (US$ Million)

Figure 72. Southeast Asia Branded Generics Revenue (2019-2030) & (US$ Million)

Figure 73. India Branded Generics Revenue (2019-2030) & (US$ Million)

Figure 74. Middle East, Africa and Latin America Branded Generics Sales Market Share by Type (2019-2030)

Figure 75. Middle East, Africa and Latin America Branded Generics Revenue Market Share by Type (2019-2030)

Figure 76. Middle East, Africa and Latin America Branded Generics Sales Market Share by Application (2019-2030)

Figure 77. Middle East, Africa and Latin America Branded Generics Revenue Market Share by Application (2019-2030)

Figure 78. Middle East, Africa and Latin America Branded Generics Revenue Share by Country (2019-2030)

Figure 79. Middle East, Africa and Latin America Branded Generics Sales Share by Country (2019-2030)

Figure 80. Brazil Branded Generics Revenue (2019-2030) & (US$ Million)

Figure 81. Mexico Branded Generics Revenue (2019-2030) & (US$ Million)

Figure 82. Turkey Branded Generics Revenue (2019-2030) & (US$ Million)

Figure 83. Israel Branded Generics Revenue (2019-2030) & (US$ Million)

Figure 84. GCC Countries Branded Generics Revenue (2019-2030) & (US$ Million)

Figure 85. Branded Generics Value Chain

Figure 86. Branded Generics Production Process

Figure 87. Channels of Distribution

Figure 88. Distributors Profiles

Figure 89. Bottom-up and Top-down Approaches for This Report

Figure 90. Data Triangulation

Figure 91. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions